{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:37:21Z","timestamp":1790030241732,"version":"4.0.1"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.clim.2023.109318","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:35:47Z","timestamp":1680521747000},"page":"109318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Neutrophil, NETs and Beh\u00e7et's disease: A review"],"prefix":"10.1016","volume":"250","author":[{"given":"Alexandre","family":"Le Joncour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Boulaftali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109318_bb0005","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(75)80031-6","article-title":"Leucocyte movement and colchicine treatment in Behcet\u2019s disease","volume":"2","author":"Matsumura","year":"1975","journal-title":"Lancet."},{"key":"10.1016\/j.clim.2023.109318_bb0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archderm.1979.04010110009014","article-title":"Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet\u2019s syndrome","volume":"115","author":"Hazen","year":"1979","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(77)92945-2","article-title":"Colchicine in Beh\u00e7et\u2019s disease","volume":"2","author":"Mizushima","year":"1977","journal-title":"Lancet."},{"key":"10.1016\/j.clim.2023.109318_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1113\/jphysiol.1908.sp001257","article-title":"Colchicine with special reference to its mode of action and effect on bone-marrow","volume":"37","author":"Dixon","year":"1908","journal-title":"J. Physiol."},{"key":"10.1016\/j.clim.2023.109318_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1254\/fpj.72.59","article-title":"Effects of drugs on leukocyte migration","volume":"72","author":"Mukaide","year":"1976","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"10.1016\/j.clim.2023.109318_bb0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/jcp.30.3.250","article-title":"Polymorphonuclear leucocyte function in Beh\u00e7et\u2019s disease","volume":"30","author":"Sobel","year":"1977","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.clim.2023.109318_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/ard.38.3.219","article-title":"Abnormal polymorphonuclear leucocyte chemotaxis in Beh\u00e7et\u2019s syndrome","volume":"38","author":"James","year":"1979","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109318_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF01617390","article-title":"The Role of Polytetrafluoroethylene Graft Material in Buerger\u2019s Disease","volume":"7","author":"Bozkurt","year":"1998","journal-title":"Int. J. Angiol."},{"key":"10.1016\/j.clim.2023.109318_bb0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2133.1985.tb02082.x","article-title":"Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet\u2019s disease","volume":"113","author":"Kaneko","year":"1985","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0190-9622(95)91333-5","article-title":"Mucocutaneous criteria for the diagnosis of Beh\u00e7et\u2019s disease: an analysis of clinicopathologic data from multiple international centers","volume":"32","author":"Jorizzo","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0055","first-page":"62","article-title":"Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Beh\u00e7et\u2019s disease","volume":"33","author":"Kose","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2559.2000.00859.x","article-title":"Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Beh\u00e7et disease","volume":"36","author":"Kobayashi","year":"2000","journal-title":"Histopathology."},{"key":"10.1016\/j.clim.2023.109318_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2559.2004.01954.x","article-title":"Neutrophilic phlebitis is characteristic of intestinal Beh\u00e7et\u2019s disease and simple ulcer syndrome","volume":"45","author":"Hayasaki","year":"2004","journal-title":"Histopathology."},{"key":"10.1016\/j.clim.2023.109318_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjo.86.2.140","article-title":"The incidence and pathology of conjunctival ulceration in Beh\u00e7et\u2019s syndrome","volume":"86","author":"Matsuo","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clim.2023.109318_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.nrl.0000263698.26284.cf","article-title":"The pathological presentations of neuro-Beh\u00e7et disease: a case report and review of the literature","volume":"13","author":"Borhani Haghighi","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.clim.2023.109318_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clineuro.2017.08.004","article-title":"Cerebral pseudo-tumoral neuro-Behcet: Histological demonstration of an inflammatory and vascular disease","volume":"161","author":"Cohen-Aubart","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clim.2023.109318_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1309\/GCTH-0060-55K8-XCTT","article-title":"Clinicopathologic Evaluation of Nodular Cutaneous Lesions of Beh\u00e7et Syndrome","volume":"116","author":"Demirkesen","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.clim.2023.109318_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0560.1989.tb00049.x","article-title":"Erythema nodosum-like lesions in Beh\u00e7et\u2019s syndrome: a histopathologic study of 30 cases","volume":"16","author":"Chun","year":"1989","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.clim.2023.109318_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3346\/jkms.2000.15.1.44","article-title":"Morphologic change of the internal elastic lamina in Buerger\u2019s disease","volume":"15","author":"Kim","year":"2000","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.clim.2023.109318_bb0100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(97)80318-0","article-title":"Cutaneous vasculitis in Beh\u00e7et\u2019s disease: a clinical and histopathologic study of 20 patients","volume":"36","author":"Chen","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13671-022-00355-8","article-title":"Neutrophilic Dermatoses: a Clinical Update","volume":"11","author":"Weiss","year":"2022","journal-title":"Curr. Dermatol. Rep."},{"key":"10.1016\/j.clim.2023.109318_bb0110","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-4362.1998.00474.x","article-title":"The histopathology of pathergy: a chronologic study of skin hyperreactivity in Beh\u00e7et\u2019s disease","volume":"37","author":"Ergun","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.1995.tb16946.x","article-title":"Immunohistology of skin pathergy reaction in Beh\u00e7et\u2019s disease","volume":"132","author":"G\u00fcl","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0120","article-title":"Risk factors of disease activity in patients with Beh\u00e7et\u2019s syndrome","author":"Hou","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0125","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/1756-185X.13404","article-title":"Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Beh\u00e7et\u2019s disease and their correlation with disease activity: A meta-analysis","volume":"21","author":"Lee","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109318_bb0130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10787-020-00701-x","article-title":"Effect of combined colchicine-corticosteroid treatment on neutrophil\/lymphocyte ratio: a predictive marker in Beh\u00e7et disease activity","volume":"28","author":"Djaballah-Ider","year":"2020","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.clim.2023.109318_bb0135","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018443","article-title":"Diagnostic value of hemoglobin and neutrophil-to-lymphocyte ratio in Behcet Disease","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2023.109318_bb0140","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10067-018-4194-z","article-title":"Neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio in Beh\u00e7et\u2019s disease: which and when to use?","volume":"37","author":"Hammad","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0145","first-page":"3045","article-title":"Neutrophil\/lymphocyte ratio and mean platelet volume in Beh\u00e7et\u2019s disease","volume":"20","author":"Balkarli","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.clim.2023.109318_bb0150","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.kjms.2015.10.010","article-title":"The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Beh\u00e7et\u2019s syndrome","volume":"31","author":"Alan","year":"2015","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.clim.2023.109318_bb0155","first-page":"65","article-title":"Neutrophil to lymphocyte ratio in Beh\u00e7et\u2019s disease as a marker of disease activity","volume":"23","author":"Rifaioglu","year":"2014","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"key":"10.1016\/j.clim.2023.109318_bb0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10067-015-2907-0","article-title":"Novel markers of endothelial dysfunction and inflammation in Beh\u00e7et\u2019s disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio","volume":"35","author":"Yuksel","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0165","first-page":"1332","article-title":"Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Beh\u00e7et\u2019s disease","volume":"24","author":"Carletto","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0170","series-title":"Polymorphonuclear function in Behget\u2019s syndrome","author":"Fordham","year":"2023"},{"key":"10.1016\/j.clim.2023.109318_bb0175","first-page":"59","article-title":"Recent research into Beh\u00e7et\u2019s disease in Japan","volume":"10","author":"Mizushima","year":"1988","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.clim.2023.109318_bb0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/ard.48.3.206","article-title":"In vivo leucocyte migration in Beh\u00e7et\u2019s syndrome","volume":"48","author":"Efthimiou","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109318_bb0185","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-4362.1998.00474.x","article-title":"The histopathology of pathergy: a chronologic study of skin hyperreactivity in Beh\u00e7et\u2019s disease","volume":"37","author":"Ergun","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.55.2.128","article-title":"Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Beh\u00e7et\u2019s disease","volume":"55","author":"Sahin","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109318_bb0195","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-009-1261-5","article-title":"Neutrophil hyperchemotaxis in Beh\u00e7et\u2019s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses","volume":"28","author":"Neves","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10067-002-8288-1","article-title":"Effect of interferon-\u03b12a on neutrophil adhesion and phagocytosis in chronic myeloid leukemia and Beh\u00e7et\u2019s disease","volume":"21","author":"Kart\u0131","year":"2002","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1155\/S0962935195000573","article-title":"Circulating intercellular adhesion molecules in blood and bronchoalveolar lavage in Beh\u00e7et\u2019s disease","volume":"4","author":"Hamzaoui","year":"1995","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2023.109318_bb0210","first-page":"608","article-title":"Peripheral leukocyte adhesion molecules in patients of Beh\u00e7et\u2019s disease associated with active ocular lesions","volume":"34","author":"Kaku","year":"1994","journal-title":"Ryumachi."},{"key":"10.1016\/j.clim.2023.109318_bb0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0035-1556727","article-title":"Endothelial Dysfunction and Altered Coagulation As Mediators of Thromboembolism in Beh\u00e7et Disease","volume":"41","author":"Butta","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.clim.2023.109318_bb0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1468-3083.2004.00547.x","article-title":"The significance of immunohistochemistry in the skin pathergy reaction of patients with Beh\u00e7et\u2019s syndrome","volume":"18","author":"Inaloz","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2023.109318_bb0225","first-page":"849","article-title":"Neutrophil CD64 expression in Beh\u00e7et\u2019s disease","volume":"32","author":"Ureten","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0230","doi-asserted-by":"crossref","first-page":"7539529","DOI":"10.1155\/2017\/7539529","article-title":"The Correlation of CD206, CD209, and Disease Severity in Beh\u00e7et\u2019s Disease with Arthritis","volume":"2017","author":"Choi","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2023.109318_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/art.42486","article-title":"Type-4 phosphodiesterase (PDE4) blockade reduces neutrophil activation in Beh\u00e7et\u2019s disease","author":"Le Joncour","year":"2023","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109318_bb0240","first-page":"S19","article-title":"Neutrophil activation in Beh\u00e7et\u2019s disease","volume":"19","author":"Eksioglu-Demiralp","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/cei.13483","article-title":"Neutrophil elastase and endogenous inhibitors in Beh\u00e7et\u2019s disease saliva","volume":"202","author":"Novak","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0009-8981(95)06033-A","article-title":"Polymorphonuclear leukocyte elastase levels in patients with Beh\u00e7et\u2019s disease","volume":"236","author":"De\u011fer","year":"1995","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clim.2023.109318_bb0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/CH-131725","article-title":"Crosstalk between inflammation, iron metabolism and endothelial function in Beh\u00e7et\u2019s disease","volume":"56","author":"Oliveira","year":"2014","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.clim.2023.109318_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-9255-9-13","article-title":"A panel of oxidative stress assays does not provide supplementary diagnostic information in Behcet\u2019s disease patients","volume":"9","author":"Akcay","year":"2012","journal-title":"J. Inflamm. (Lond)."},{"key":"10.1016\/j.clim.2023.109318_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","article-title":"Increased advanced oxidation protein products in Beh\u00e7et\u2019s disease: a new activity marker?","volume":"151","author":"Yazici","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0270","first-page":"12","article-title":"Oxidases and oxygenases in regulation of neutrophil redox pathways in Beh\u00e7et\u2019s disease patients, Journal of Enzyme Inhibition and Medicinal","volume":"27","author":"Melikoglu","year":"2012","journal-title":"Chemistry."},{"key":"10.1016\/j.clim.2023.109318_bb0275","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5021\/ad.2011.23.3.313","article-title":"Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Beh\u00e7et\u2019s Disease and Its Association with Disease Activity: A Pilot Study","volume":"23","author":"Han","year":"2011","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0280","first-page":"230","article-title":"Evaluation of hbetaD-1 and hbetaD-2 levels in saliva of patients with oral mucosal diseases","volume":"62","author":"Kucukkolbasi","year":"2013","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.clim.2023.109318_bb0285","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jbspin.2011.01.012","article-title":"Increased \u03b1-defensin-1 expression in Korean patients with Behcet\u2019s disease","volume":"78","author":"Ahn","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clim.2023.109318_bb0290","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1365-4632.2012.05504.x","article-title":"Salivary levels of HNP 1\u20133 are related to oral ulcer activity in Beh\u00e7et\u2019s disease","volume":"52","author":"Mumcu","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0295","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.archoralbio.2011.11.003","article-title":"Salivary levels of antimicrobial peptides Hnp 1\u20133, Ll-37 and S100 in Behcet\u2019s disease","volume":"57","author":"Mumcu","year":"2012","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.clim.2023.109318_bb0300","first-page":"S85","article-title":"Beh\u00e7et\u2019s disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations","volume":"33","author":"Perazzio","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0305","first-page":"S17","article-title":"The effects of nitric oxide donors and inhibitors on neutrophil functions in Beh\u00e7et\u2019s disease","volume":"20","author":"Atalay","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1034\/j.1600-0463.2001.d01-111.x","article-title":"In vitro Candidacidal effect of polymorphonuclear neutrophils of Beh\u00e7et\u2019s patients with or without ocular involvement","volume":"109","author":"Tekeli","year":"2001","journal-title":"APMIS."},{"key":"10.1016\/j.clim.2023.109318_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2018.03.049","article-title":"Neutrophils and redox stress in the pathogenesis of autoimmune disease","volume":"125","author":"Glennon-Alty","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.clim.2023.109318_bb0320","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive Oxygen Species in Inflammation and Tissue Injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.clim.2023.109318_bb0325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00296-002-0195-x","article-title":"Trace elements and antioxidant enzymes in Beh\u00e7et\u2019s disease","volume":"22","author":"Saglam","year":"2002","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2023.109318_bb0330","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10067-006-0513-x","article-title":"Oxidant\/antioxidant status in men with Beh\u00e7et\u2019s disease","volume":"26","author":"Taysi","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10715769809097874","article-title":"Serum of Beh\u00e7et\u2019s disease enhances superoxide production of normal neutrophils","volume":"28","author":"Yoshida","year":"1998","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.clim.2023.109318_bb0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13075-017-1443-5","article-title":"Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Beh\u00e7et\u2019s disease","volume":"19","author":"Perazzio","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2023.109318_bb0345","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ejim.2008.08.001","article-title":"Oxidative stress: correlation with Beh\u00e7et\u2019s disease duration, activity and severity","volume":"19","author":"Harzallah","year":"2008","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.clim.2023.109318_bb0350","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1346-8138.2007.00278.x","article-title":"Oxidative stress in patients with Behcet\u2019s disease: I correlation with severity and clinical parameters, The","volume":"34","author":"Najim","year":"2007","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0355","first-page":"343","article-title":"Oxidative stress in adamantiades-Beh\u00e7et\u2019s disease","volume":"197","author":"Freitas","year":"1998","journal-title":"DRM."},{"key":"10.1016\/j.clim.2023.109318_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214335","article-title":"Critical role of neutrophil extracellular traps (NETs) in patients with Behcet\u2019s disease","author":"Le Joncour","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109318_bb0365","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":"Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet\u2019s disease","volume":"33","author":"Akdeniz","year":"2004","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.clim.2023.109318_bb0370","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","article-title":"Vascular endothelial function and oxidative stress mechanisms in patients with Beh\u00e7et\u2019s syndrome","volume":"37","author":"Chambers","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clim.2023.109318_bb0375","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00232-011-9404-4","article-title":"Colchicine modulates oxidative stress in serum and neutrophil of patients with Beh\u00e7et disease through regulation of Ca2+ release and antioxidant system","volume":"244","author":"Korkmaz","year":"2011","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.clim.2023.109318_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135856","article-title":"A comparative metabolomic evaluation of Behcet\u2019s disease with arthritis and seronegative arthritis using synovial fluid","volume":"10","author":"Ahn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109318_bb0385","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","article-title":"Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behcet Disease","volume":"133","author":"Becatti","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.clim.2023.109318_bb0390","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","article-title":"Excessive function of peripheral blood neutrophils from patients with Beh\u00e7et\u2019s disease and from HLA-B51 transgenic mice","volume":"38","author":"Takeno","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109318_bb0395","first-page":"1029","article-title":"Induction of Beh\u00e7et\u2019s disease symptoms after dental treatment and streptococcal antigen skin test","volume":"15","author":"Mizushima","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0400","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0036933018801215","article-title":"Behcet\u2019s disease and severe inflammatory reaction to 23-valent pneumococcal polysaccharide vaccine: a case report and review of literature","volume":"63","author":"Saeidinejad","year":"2018","journal-title":"Scott. Med. J."},{"key":"10.1016\/j.clim.2023.109318_bb0405","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/rheumatology\/ker388","article-title":"Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet\u2019s disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine","volume":"51","author":"H\u00fcgle","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109318_bb0410","first-page":"keac543","article-title":"Improved sensitivity of skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Beh\u00e7et disease","author":"Deniz","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109318_bb0415","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/ken109","article-title":"Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet\u2019s disease","volume":"47","author":"Do","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109318_bb0420","first-page":"200","article-title":"Macrophage activation by leptospiral lipopolysaccharide, Zentralblatt Fur Bakteriologie","volume":"273","author":"Isogai","year":"1990","journal-title":"Inte. J. Med. Microbiol."},{"key":"10.1016\/j.clim.2023.109318_bb0425","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00296-007-0470-y","article-title":"Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet\u2019s disease etiopathogenesis","volume":"28","author":"Yavuz","year":"2008","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2023.109318_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109161","article-title":"Transcriptional analysis of neutrophils from patients with Beh\u00e7et\u2019s disease reveals activation and chemotaxis of neutrophils","volume":"245","author":"Yu","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0435","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.4049\/jimmunol.175.11.7678","article-title":"T Cell-Regulated Neutrophilic Inflammation in Autoinflammatory Diseases","volume":"175","author":"Keller","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0440","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","article-title":"Significance of serum interleukin-8 levels in patients with Behcet\u2019s disease: high levels may indicate vascular involvement","volume":"48","author":"Durmazlar","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0445","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-4632.2004.02184.x","article-title":"Serum interleukin-8 as a serologic marker of activity in Beh\u00e7et\u2019s disease","volume":"44","author":"G\u00fcr-Toy","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0450","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3389\/fneur.2019.01102","article-title":"Behcet\u2019s Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8","volume":"10","author":"Yin","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2023.109318_bb0455","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1346-8138.1994.tb01762.x","article-title":"Interleukin 8 in Beh\u00e7et\u2019s disease","volume":"21","author":"Itoh","year":"1994","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0460","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000018426","article-title":"Adamantiades-Beh\u00e7et\u2019s disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate","volume":"201","author":"Katsantonis","year":"2000","journal-title":"Dermatology."},{"key":"10.1016\/j.clim.2023.109318_bb0465","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcla.21772","article-title":"Serum Cytokine Levels in Beh\u00e7et\u2019s Disease","volume":"29","author":"Akkurt","year":"2015","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.clim.2023.109318_bb0470","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.140.5.570","article-title":"Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction","volume":"140","author":"Kawakami","year":"2004","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2023.109318_bb0475","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar4147","article-title":"Expression of regulatory receptors on \u03b3\u03b4 T cells and their cytokine production in Behcet\u2019s disease","volume":"15","author":"Parlakgul","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.clim.2023.109318_bb0480","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s004030000128","article-title":"Adamantiades-Beh\u00e7et\u2019s disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells","volume":"292","author":"Zouboulis","year":"2000","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2023.109318_bb0485","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","article-title":"Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Beh\u00e7et\u2019s disease","volume":"18","author":"Adam","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2023.109318_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Behcet\u2019s Disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0495","first-page":"S70","article-title":"Serum MMP-2 and MMP-9 in patients with Beh\u00e7et\u2019s disease: do their higher levels correlate to vasculo-Beh\u00e7et\u2019s disease associated with aneurysm formation?","volume":"25","author":"Pay","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0500","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0505","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.0903162","article-title":"IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation","volume":"184","author":"Roussel","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0510","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/mi.2016.80","article-title":"IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria","volume":"10","author":"Flannigan","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0515","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Beh\u00e7et disease","volume":"128","author":"Geri","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0520","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2011.07.008","article-title":"Regulation of TH17 and regulatory T cells in patients with Beh\u00e7et disease","volume":"128","author":"Direskeneli","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0525","first-page":"65","article-title":"CD4+ T cells from behcet patients produce high levels of IL-17","volume":"26","author":"Chi","year":"2011","journal-title":"Eye Sci."},{"key":"10.1016\/j.clim.2023.109318_bb0530","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et\u2019s disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0535","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01451044","article-title":"Thrombomodulin levels in Beh\u00e7et\u2019s disease with and without the factor V Leiden mutation","volume":"17","author":"G\u00fcrgey","year":"1998","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0540","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/clim.1999.4687","article-title":"Enhancement of endothelial cell E-selectin expression by sera from patients with active Beh\u00e7et\u2019s disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels","volume":"91","author":"Triolo","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0545","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1155\/MI.2005.237","article-title":"Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Beh\u00e7et\u2019s syndrome","volume":"2005","author":"Turkoz","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2023.109318_bb0550","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10067-004-0982-8","article-title":"Levels of soluble E-selectin in patients with active Beh\u00e7et\u2019s disease","volume":"24","author":"Sari","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0555","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s10067-006-0449-1","article-title":"Endothelial functions are more severely impaired during active disease period in patients with Behcet\u2019s disease","volume":"26","author":"Caliskan","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0560","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.thromres.2006.02.008","article-title":"Decreased nitric oxide and increased platelet aggregation levels in patients with Beh\u00e7et\u2019s disease","volume":"119","author":"Yapi\u015flar","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2023.109318_bb0565","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1076029606293430","article-title":"Circulated activated platelets and increased platelet reactivity in patients with Beh\u00e7et\u2019s disease","volume":"12","author":"Akar","year":"2006","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.clim.2023.109318_bb0570","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/rheumatology\/ker177","article-title":"Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Beh\u00e7et\u2019s disease","volume":"50","author":"Macey","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109318_bb0575","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2362.1988.tb01032.x","article-title":"Decreased prostacyclin sensitivity of platelets in patients with Beh\u00e7et\u2019s syndrome","volume":"18","author":"Wilson","year":"1988","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.clim.2023.109318_bb0580","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH11-08-0556","article-title":"Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Beh\u00e7et disease patients","volume":"107","author":"Fern\u00e1ndez Bello","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109318_bb0585","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/BOR.0000000000000846","article-title":"The association of Beh\u00e7et\u2019s syndrome with HLA-B51 as understood in 2021","volume":"34","author":"Takeno","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0590","first-page":"S46","article-title":"Activation of neutrophils by testosterone in Beh\u00e7et\u2019s disease","volume":"25","author":"Yavuz","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2023.109318_bb0595","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109318_bb0600","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1172\/JCI84538","article-title":"Neutrophil extracellular traps - the dark side of neutrophils","volume":"126","author":"Sorensen","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109318_bb0605","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109318_bb0610","first-page":"309","article-title":"Presence of neutrophil extracellular traps and antineutrophil cytoplasmic antibodies associated with vasculitides","volume":"1","author":"Abreu-Velez","year":"2009","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.clim.2023.109318_bb0615","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109318_bb0620","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/STROKEAHA.117.019896","article-title":"Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke","volume":"49","author":"Ducroux","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.clim.2023.109318_bb0625","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2023.109318_bb0630","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jdermsci.2018.08.010","article-title":"Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Beh\u00e7et\u2019s disease","volume":"92","author":"Safi","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2023.109318_bb0635","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13664","article-title":"Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Beh\u00e7et\u2019s syndrome","author":"Bettiol","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0640","article-title":"Neutrophil extracellular traps promote aberrant macrophages activation in Beh\u00e7et\u2019s disease","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0645","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41584-022-00880-7","article-title":"Vascular Beh\u00e7et syndrome: from pathogenesis to treatment","volume":"19","author":"Bettiol","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2018","key":"10.1016\/j.clim.2023.109318_bb0650","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109318_bb0655","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3389\/fimmu.2019.01085","article-title":"Beh\u00e7et\u2019s syndrome as a model of thrombo-inflammation: the role of neutrophils","volume":"10","author":"Emmi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0660","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2018-11-886267","article-title":"Challenging the concept of immunothrombosis","volume":"133","author":"Palankar","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109318_bb0665","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/cei.13243","article-title":"Beh\u00e7et\u2019s syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects","volume":"195","author":"Becatti","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0670","article-title":"Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis","volume":"13","author":"Zhang","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.clim.2023.109318_bb0675","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.autrev.2018.02.012","article-title":"Autosomic dominant familial Beh\u00e7et disease and haploinsufficiency A20: A review of the literature","volume":"17","author":"Berteau","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109318_bb0680","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29287-9","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation","volume":"299","author":"Jimenez","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.clim.2023.109318_bb0685","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40265-019-01253-3","article-title":"Apremilast: a review in oral ulcers of Beh\u00e7et\u2019s disease","volume":"80","author":"Deeks","year":"2020","journal-title":"Drugs."},{"key":"10.1016\/j.clim.2023.109318_bb0690","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.clim.2023.109318_bb0695","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Beh\u00e7et\u2019s syndrome--a phase 2, placebo-controlled study","volume":"372","author":"Hatemi","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109318_bb0700","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","article-title":"Trial of Apremilast for Oral Ulcers in Beh\u00e7et\u2019s Syndrome","volume":"381","author":"Hatemi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109318_bb0705","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12973","article-title":"Beh\u00e7et disease (BD) and BD-like clinical phenotypes: NF-kB pathway in mucosal ulcerating diseases","author":"Perazzio","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0710","article-title":"Distinct transcriptional profile of blood mononuclear cells in Beh\u00e7et\u2019s disease: insights into the central role of neutrophil chemotaxis","volume":"60","author":"Km","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.clim.2023.109318_bb0715","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.clim.2023.109318_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124090","article-title":"How glucocorticoids affect the neutrophil life","volume":"19","author":"Ronchetti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2023.109318_bb0725","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(03)02153-8","article-title":"Inhibitory capacity of different steroids on neutrophil migration across a bilayer of endothelial and bronchial epithelial cells","volume":"477","author":"van Overveld","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.clim.2023.109318_bb0730","doi-asserted-by":"crossref","first-page":"3021863","DOI":"10.1155\/2018\/3021863","article-title":"Anti-TNF-\u03b1 therapy suppresses proinflammatory activities of mucosal neutrophils in inflammatory bowel disease","volume":"2018","author":"Zhang","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2023.109318_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108516","article-title":"Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality","volume":"104","author":"Al-Kuraishy","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2023.109318_bb0740","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109318_bb0745","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.4049\/jimmunol.1001620","article-title":"N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis","volume":"186","author":"Willis","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109318_bb0750","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrneph.2016.71","article-title":"The role of neutrophils and NETosis in autoimmune and renal diseases","volume":"12","author":"Gupta","year":"2016","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:08:36Z","timestamp":1761494916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":150,"alternative-id":["S1521661623000979"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109318","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil, NETs and Beh\u00e7et's disease: A review","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109318"}}